Home>Home Page Articles>Accelerating Molecules to Market
Accelerating Molecules to Market
Merck is improving biopharma companies’ scalability with single-use technology
Traditionally, biopharmaceutical companies used large stainless steel vessels in multi-story buildings, requiring substantial investment and rigorous setup. By using single-use disposable equipment instead, customers get improved batch turnaround times, reduced risk of product cross-contamination, decreased capital costs and have less equipment to clean. Merck’s Mobius® single-use bioreactors help accelerate customers’ molecules to market, improve productivity, and ensure supply continuity.
More Information
Press Release
